Cargando…
Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles
BACKGROUND: Development of new drug carriers would be an interesting approach if it allowed increased efficacy of antibiotics and a reduction in doses, thus reducing the risk of developing resistance. As with most drug carriers, niosomes have been used to improve the selective delivery and the thera...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483317/ https://www.ncbi.nlm.nih.gov/pubmed/26140184 |
_version_ | 1782378534875955200 |
---|---|
author | Akbari, Vajihe Abedi, Daryoush Pardakhty, Abbas Sadeghi-Aliabadi, Hojjat |
author_facet | Akbari, Vajihe Abedi, Daryoush Pardakhty, Abbas Sadeghi-Aliabadi, Hojjat |
author_sort | Akbari, Vajihe |
collection | PubMed |
description | BACKGROUND: Development of new drug carriers would be an interesting approach if it allowed increased efficacy of antibiotics and a reduction in doses, thus reducing the risk of developing resistance. As with most drug carriers, niosomes have been used to improve the selective delivery and the therapeutic index of antimicrobial agents. METHODS: In this study, different formulation of niosomes containing ciprofloxacin (CPFX), Span (20, 60 or 80), Tween (20, 60 or 80) and cholesterol were prepared by film hydration method. The release of the drug from different formulations was studied by using Franz diffusion cell. The niosomes were further characterized by optical microscopy and particle size analysis, and their antimicrobial activity was evaluated. RESULTS: Size of the niosomes was significantly dependent on the amount of cholesterol and surfactant type and varied from 8.56 to 61.3 μm. The entrapment efficiency of CPFX niosomes prepared by remote loading was more than 74%. Niosomes composed of Span/Tween 60 provided a higher CPFX release rate than other formulations. The obtained results indicated a diffusion-based mechanism for drug leakage through bilayers. All formulations presented more antibacterial activity as compared to free CPFX solution. CONCLUSION: Niosomal CPFX appears to be a promising approach in the management of bacterial infections, especially ophthalmic ones, and should be further evaluated by in vivo experiments. |
format | Online Article Text |
id | pubmed-4483317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Avicenna Research Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-44833172015-07-02 Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles Akbari, Vajihe Abedi, Daryoush Pardakhty, Abbas Sadeghi-Aliabadi, Hojjat Avicenna J Med Biotechnol Original Article BACKGROUND: Development of new drug carriers would be an interesting approach if it allowed increased efficacy of antibiotics and a reduction in doses, thus reducing the risk of developing resistance. As with most drug carriers, niosomes have been used to improve the selective delivery and the therapeutic index of antimicrobial agents. METHODS: In this study, different formulation of niosomes containing ciprofloxacin (CPFX), Span (20, 60 or 80), Tween (20, 60 or 80) and cholesterol were prepared by film hydration method. The release of the drug from different formulations was studied by using Franz diffusion cell. The niosomes were further characterized by optical microscopy and particle size analysis, and their antimicrobial activity was evaluated. RESULTS: Size of the niosomes was significantly dependent on the amount of cholesterol and surfactant type and varied from 8.56 to 61.3 μm. The entrapment efficiency of CPFX niosomes prepared by remote loading was more than 74%. Niosomes composed of Span/Tween 60 provided a higher CPFX release rate than other formulations. The obtained results indicated a diffusion-based mechanism for drug leakage through bilayers. All formulations presented more antibacterial activity as compared to free CPFX solution. CONCLUSION: Niosomal CPFX appears to be a promising approach in the management of bacterial infections, especially ophthalmic ones, and should be further evaluated by in vivo experiments. Avicenna Research Institute 2015 2015-04 /pmc/articles/PMC4483317/ /pubmed/26140184 Text en Copyright© 2015 Avicenna Research Institute This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Akbari, Vajihe Abedi, Daryoush Pardakhty, Abbas Sadeghi-Aliabadi, Hojjat Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles |
title | Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles |
title_full | Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles |
title_fullStr | Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles |
title_full_unstemmed | Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles |
title_short | Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles |
title_sort | release studies on ciprofloxacin loaded non-ionic surfactant vesicles |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483317/ https://www.ncbi.nlm.nih.gov/pubmed/26140184 |
work_keys_str_mv | AT akbarivajihe releasestudiesonciprofloxacinloadednonionicsurfactantvesicles AT abedidaryoush releasestudiesonciprofloxacinloadednonionicsurfactantvesicles AT pardakhtyabbas releasestudiesonciprofloxacinloadednonionicsurfactantvesicles AT sadeghialiabadihojjat releasestudiesonciprofloxacinloadednonionicsurfactantvesicles |